Search
News
Andersen Group Q2 2026 Earnings: Revenue Rises 23.7% as Adjusted Margins Expand
Andersen Group’s (NYSE: ANDG) Q2 2026 revenue rose 23.7% year over year to $217.7 million, while its GAAP net loss narrowed to $10.1 million from $96.0 million as non-cash equity compensation declined. Adjusted net income increased 38.8% to $39.0 million, and adjusted EBITDA margin expanded to 21.1% from 16.9%. Every service line grew, with Business Tax Services gaining revenue mix share, while international acquisitions added a 2.5% contribution. Andersen reaffirmed full-year revenue guidance of approximately $980 million to $1.0 billion.
TradingKey
Wed, Aug 12
EnerSys Q1 Fiscal 2027 Earnings: Wider Margins Lift EPS
EnerSys reported fiscal Q1 2027 net sales of $935.6 million, up 4.8%, and GAAP diluted EPS of $3.09, up 112%. Gross margin widened 510 basis points to 33.5%, while adjusted diluted EPS reached $3.66. Results benefited from IRC 45X credits and $30.9 million of tariff refunds, although adjusted EPS excluding both still increased 42% to $1.78. Operating cash flow rose to $230.2 million, and second-quarter sales guidance was set at $955 million to $995 million.
TradingKey
Wed, Aug 12
Securitize Q2 2026 earnings: Revenue slips as higher costs push adjusted EBITDA negative
Securitize (NYSE: SECZ) reported Q2 2026 revenue of $14.4 million, down 5% year over year, while diluted loss per share widened to $2.37 from $0.72. Average tokenized AUM rose 16% to $4.3 billion and aggregate transaction volume jumped 147% to $5.3 billion, but adjusted EBITDA swung to a $5.5 million loss from a $1.8 million profit. Higher operating expenses and liability fair-value changes drove the wider GAAP loss, while the post-quarter business combination materially strengthened liquidity and left management focused on restoring positive adjusted EBITDA.TradingKey
Wed, Aug 12
STAAR Surgical Q2 2026 Earnings: China Rebound Restores Profitability
STAAR Surgical’s Q2 2026 net sales rose 111% to $93.5 million, while GAAP diluted EPS improved to $0.16 from a $0.34 loss and adjusted EBITDA reached $20.0 million versus a $14.8 million loss. China generated $52.3 million, more than half of revenue, as shipments normalized after a prior-year inventory drawdown and EVO+ adoption, volume, and pricing mix improved. Gross margin edged up to 74.5%, although tariffs and costs embedded in lenses produced at lower 2025 volumes remained offsets. Investors should watch China seasonality and the unusually difficult Q3 comparison.
TradingKey
Wed, Aug 12
AOS Fiscal Q4 2026 Earnings: Margins Recovered Sequentially, but Core Losses Persisted
Alpha and Omega Semiconductor (AOS) reported fiscal Q4 2026 revenue of $170.4 million, down 3.5% year over year, with a GAAP diluted loss of $0.43 per share versus $2.58 a year earlier. GAAP gross margin reached 23.1%, improving 200 basis points sequentially but slipping 30 basis points year over year. Advanced Computing and Communications offset continued traditional PC weakness, while operating cash use was $10.0 million. For fiscal Q1 2027, AOS guided to $176 million in revenue at the midpoint and a 23.8% GAAP gross margin.
TradingKey
Wed, Aug 12
Omeros Q2 2026 Earnings: YARTEMLEA Drives Operating Break-Even
Omeros reported Q2 2026 net product sales of $28.5 million, up from zero a year earlier, as YARTEMLEA gross revenue reached $32.2 million and rose 190% from Q1. GAAP net income was $13.2 million, with basic EPS of $0.18, but included an $11.5 million non-cash fair-value gain; non-GAAP adjusted net income was $1.8 million. Operations generated $4.1 million of cash, while June-end cash and short-term investments totaled $132.0 million before a $60.2 million convertible-note repurchase completed in July.
TradingKey
Wed, Aug 12
AEVEX Q2 2026 Earnings: Tactical Systems Drives 99.5% Revenue Growth
AEVEX reported Q2 2026 revenue of $201.8 million, up 99.5% year over year, while net income improved to $6.7 million from an $11.8 million loss. Adjusted EBITDA rose to $28.1 million with a 13.9% margin, led by Tactical Systems and $72.2 million from the EUCOM AOR Deep Strike program. Funded backlog fell to $259.8 million as Deep Strike work converted into revenue. Management raised full-year guidance to $700 million-$720 million of revenue and $105 million-$111.5 million of adjusted EBITDA, excluding BlackSea Technologies.TradingKey
Wed, Aug 12
Spire Q2 2026 Earnings: Core Revenue Grew but Gross Margin Fell
Spire Global’s Q2 2026 revenue fell 6% to $18.0 million but increased 16% excluding the divested maritime business. GAAP gross margin dropped 16 percentage points to 34% after the WildFireSat contract was canceled, while the adjusted EBITDA loss improved 16% to $8.6 million as operating expenses declined. Spire used $23.4 million of operating cash, ended June with $91.7 million in cash and marketable securities and no debt, and reaffirmed FY2026 revenue guidance of $75 million to $85 million.
TradingKey
Wed, Aug 12
Kimball Electronics Q4 FY2026 earnings: Disposal gain lifts GAAP profit as adjusted earnings weaken
Kimball Electronics’ fiscal Q4 2026 net sales fell 2% to $371.6 million, while GAAP diluted EPS increased to $0.35 from $0.26. A $15.0 million disposal gain lifted reported operating income, but adjusted operating margin narrowed to 4.9% and adjusted EPS swung to a $0.01 loss. Operating cash flow reached $42.4 million, debt declined to $116.6 million, and fiscal 2027 guidance calls for 7%-9% sales growth, including 3%-5% organic growth and about $60 million from Helvoet. Acquisition execution and soft automotive and industrial demand remain key considerations.
TradingKey
Wed, Aug 12
Intellinetics Q2 2026 earnings: Services weakness and higher costs widen losses
Intellinetics (INLX) reported Q2 2026 revenue of $3.95 million, down 1.6% year over year, and a net loss of $1.09 million, versus $0.57 million a year earlier. Loss per share widened to $0.24 from $0.13, while adjusted EBITDA moved to a $0.37 million loss. SaaS revenue grew 4.2%, but lower professional services and maintenance revenue, weaker services margins, and a 14.7% increase in operating expenses pressured results. Management reaffirmed double-digit fiscal 2026 SaaS growth guidance, and cash ended the quarter at $1.71 million.
TradingKey
Wed, Aug 12
Tiendas 3B Q2 2026 Earnings: Revenue Growth Outpaces Reported Profitability
Tiendas 3B reported Q2 2026 revenue of Ps. 26.04 billion, up 38.7% year over year, as same-store sales rose 20.0% and the chain added 155 net new stores. Gross margin expanded 54 basis points to 16.8%, while EBITDA excluding share-based payments increased 43.8% to Ps. 1.58 billion. However, Ps. 615 million of non-cash share-based compensation and higher administrative costs limited reported EBITDA growth and contributed to a wider Ps. 386 million net loss. First-half operating cash flow more than doubled, supporting continued network expansion.
TradingKey
Wed, Aug 12
Knightscope Q2 2026 Earnings: Revenue Reaches $9.0 Million as Gross Margin Turns Positive
Knightscope’s Q2 2026 revenue rose 228% year over year to a record $9.0 million, driven by a full-quarter contribution from the acquired Security Force. Gross profit turned positive at $0.7 million, equal to approximately 7% of revenue, versus a $0.9 million gross loss a year earlier. However, operating expenses climbed to $13.8 million and the net loss widened to $14.1 million, even as loss per share narrowed to $0.79. Knightscope ended June with $8.2 million in cash and expects initial K7 deployments in Q4 2026.
TradingKey
Wed, Aug 12
Resideo Q2 2026 earnings: Adjusted EBITDA rises 19% on margin gains
Resideo’s fiscal Q2 2026 revenue rose 2% to $1.981 billion, while adjusted EBITDA increased 19% to $249 million and adjusted EPS advanced 26% to $0.83. Gross margin expanded 70 basis points to 30.0%, helped by $27 million of tariff refunds, but operating cash flow fell to $148 million as separation and settlement payments and higher cash interest weighed. Because the ADI spin-off closed after quarter-end, Q2 still includes ADI. Resideo’s new standalone 2026 outlook calls for $2.90 billion to $2.95 billion of revenue and $605 million to $625 million of adjusted EBITDA.
TradingKey
Wed, Aug 12
Sera Prognostics Q2 2026 Earnings: Commercial Progress Has Yet to Produce Material Revenue
Sera Prognostics reported Q2 2026 revenue of $30,000, up from $17,000 a year earlier, while diluted net loss per share widened to $0.18 from $0.16. Net loss increased to $9.1 million as operating expenses rose on commercial investment, strategic hiring and restructuring-related R&D costs. The company ended June with $80.3 million in cash and securities and highlighted expanding payer engagement, Illinois Medicaid coverage and rising testing volume. Investors will need to monitor whether broader access converts into reimbursed test volume.
TradingKey
Wed, Aug 12
Identiv Q2 2026 earnings: Manufacturing savings restore a positive gross margin
Identiv’s Q2 2026 revenue increased 12.7% year over year to $5.7 million, while GAAP gross margin improved to 16.1% from -9.4%. The GAAP net loss narrowed to $4.7 million, and diluted EPS improved to -$0.20 from -$0.26. Adjusted EBITDA loss fell to $2.7 million as manufacturing savings and better Thailand utilization supported profitability. Near-term demand is constrained by a large customer’s inventory pause and chip allocation delays. Q3 revenue guidance is $4.1 million to $4.8 million and excludes the pending Trackonomy asset sale, expected to close in fiscal Q3 subject to conditions.
TradingKey
Wed, Aug 12
Red Robin Fiscal Q2 2026 Earnings: Restaurant Margin Rises as Revenue and EBITDA Decline
Red Robin’s fiscal Q2 2026 revenue fell approximately 2.1% year over year to $277.6 million, while diluted EPS declined to $0.02 from $0.21. Comparable restaurant revenue rose 1.3% as a 1.5% increase in average check offset a 0.2% traffic decline, and restaurant-level operating margin improved 20 basis points to 14.7%. Higher selling expense contributed to lower operating income and adjusted EBITDA. The company reaffirmed fiscal 2026 guidance and expects $96 million in gross proceeds from pending refranchising agreements covering 116 restaurants.
TradingKey
Wed, Aug 12
CVD Equipment Q2 2026 Earnings: SDC Sale Lifts Cash as Revenue Falls 42.6%
CVD Equipment’s Q2 2026 revenue fell 42.6% year over year to $2.0 million, while the continuing-operations loss widened to $1.4 million, or $0.20 per diluted share. Total net income reached $12.6 million, primarily because the SDC divestiture produced $13.9 million of discontinued-operations income. The sale also lifted quarter-end cash to $23.5 million and left the company without long-term debt. Gross margin improved to 16.8% on a higher mix of non-system revenue, but orders and backlog declined amid economic and geopolitical uncertainty.
TradingKey
Wed, Aug 12
Wrap Technologies Q2 2026 Earnings: Revenue Rises 103% as Gross Margin Reaches 75%
Wrap Technologies reported Q2 2026 revenue of $2.1 million, up 103% year over year, while gross margin expanded to approximately 75% from 48%. Gross profit rose 217% to $1.5 million, and net loss narrowed 39% to $2.3 million. Cash and cash equivalents reached $4.8 million at June 30. Management did not revise its previously disclosed 100% revenue growth target for 2026 but cautioned that revenue-recognition timing could affect final results. A post-quarter regulatory classification also broadened BolaWrap’s potential applications.
TradingKey
Wed, Aug 12
Neonode Q2 2026 earnings: Engineering revenue decline outweighs licensing growth
Neonode’s Q2 2026 revenue from continuing operations fell 20.4% to $0.5 million, while its loss widened to $2.1 million, or $0.13 per share, from $2.0 million, or $0.12 per share. License revenue increased 9.2% to $0.4 million, but an 81.5% decline in non-recurring engineering revenue outweighed the gain. Operating cash use rose to $1.9 million, while MultiSensing license revenue grew more than fivefold. Cash and accounts receivable totaled $21.7 million at quarter-end, down from $25.8 million at December 31, 2025.
TradingKey
Wed, Aug 12
Spruce Biosciences Q2 2026 Results: Expenses Rise Ahead of the TA-ERT Filing
Spruce Biosciences reported a Q2 2026 net loss of $16.2 million, or $6.68 per diluted share, compared with $2.1 million and $3.50 a year earlier. Operating expenses rose to $16.5 million as TA-ERT manufacturing, clinical development, staffing and pre-launch work increased. Cash and equivalents reached $96.3 million at June 30, and management said the balance should fund planned operations and debt obligations into the second half of 2027. The company continues to target a fourth-quarter 2026 TA-ERT BLA submission and TrAnsform study launch.
TradingKey
Wed, Aug 12
Featured Tools
Top News
The Week Ahead: Fed Minutes, Walmart, Target and Home Depot Earnings to Test US Consumer Resilience
Broadcom Stock Price Forecast: Can It Break $500 Before Earnings Amid Strong Custom AI Chip Demand?
SK Hynix Stock Forecast: Can HBM4 Demand Drive a Breakout Toward $194?
Tesla Stock Price Prediction: SpaceX Thruster-Equipped Roadster May Debut This Month, Could It Boost TSLA Stock?
Palantir Calls Q2 "Otherworldly" and Raises Guidance — Will Jackson Hole Derail the AI Sovereignty Momentum?
